BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 19224939)

  • 1. Chemotherapy with cisplatin and vincristine for optic pathway/hypothalamic astrocytoma in young children.
    Sawamura Y; Kamoshima Y; Kato T; Tajima T; Tsubaki J
    Jpn J Clin Oncol; 2009 May; 39(5):277-83. PubMed ID: 19224939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin/vincristine chemotherapy for hypothalamic/visual pathway astrocytomas in young children.
    Kato T; Sawamura Y; Tada M; Ikeda J; Ishii N; Abe H
    J Neurooncol; 1998 May; 37(3):263-70. PubMed ID: 9524084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of chiasmatic-hypothalamic gliomas in children: report of nine pediatric cases].
    Akiyama H; Nakamizo S; Kawamura A; Nagashima T; Takeda H; Hasegawa D; Kosaka Y; Yoshida M
    No Shinkei Geka; 2007 Nov; 35(11):1079-85. PubMed ID: 18044225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
    Gnekow AK; Kortmann RD; Pietsch T; Emser A
    Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diencephalic syndrome: a frequently delayed diagnosis in failure to thrive.
    Huber J; Sovinz P; Lackner H; Mokry M; Eder H; Urban C
    Klin Padiatr; 2007; 219(2):91-4. PubMed ID: 17405074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vincristine and carboplatin chemotherapy for unresectable and/or recurrent low-grade astrocytoma of the brainstem.
    Ronghe M; Hargrave D; Bartels U; Tabori U; Vaidya S; Chandler C; Kulkarni A; Bouffet E
    Pediatr Blood Cancer; 2010 Sep; 55(3):471-7. PubMed ID: 20535831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing the dosage of vincristine: a clinical and pharmacokinetic study of continuous-infusion vincristine in children with central nervous system tumors.
    Kellie SJ; Koopmans P; Earl J; Nath C; Roebuck D; Uges DR; De Graaf SS
    Cancer; 2004 Jun; 100(12):2637-43. PubMed ID: 15197807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute signs and symptoms of toxicity due to the BOPP regimen (BCNU, vincristine, procarbazine, cisplatin) during treatment of high-grade astrocytoma].
    Jeremić B; Grujicić D; Jevremović S; Mijatović Lj
    Srp Arh Celok Lek; 1991; 119(9-10):256-8. PubMed ID: 1806994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotherapy.
    Petronio J; Edwards MS; Prados M; Freyberger S; Rabbitt J; Silver P; Levin VA
    J Neurosurg; 1991 May; 74(5):701-8. PubMed ID: 1901597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optic pathway hypothalamic gliomas in children under three years of age: the role of chemotherapy.
    Silva MM; Goldman S; Keating G; Marymont MA; Kalapurakal J; Tomita T
    Pediatr Neurosurg; 2000 Sep; 33(3):151-8. PubMed ID: 11096362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of pilomyxoid astrocytomas: our experience.
    Tsugu H; Oshiro S; Yanai F; Komatsu F; Abe H; Fukushima T; Nomura Y; Matsumoto S; Nabeshima K; Takano K; Utsunomiya H
    Anticancer Res; 2009 Mar; 29(3):919-26. PubMed ID: 19414328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy for unresectable and recurrent intramedullary glial tumours in children. Brain Tumours Subcommittee of the French Society of Paediatric Oncology (SFOP).
    Doireau V; Grill J; Zerah M; Lellouch-Tubiana A; Couanet D; Chastagner P; Marchal JC; Grignon Y; Chouffai Z; Kalifa C
    Br J Cancer; 1999 Nov; 81(5):835-40. PubMed ID: 10555754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of metronomic chemotherapy with thalidomide, carboplatin-vincristine-fluvastatin in the treatment of brain stem tumors in children.
    López-Aguilar E; Sepúlveda-Vildósola AC; Betanzos-Cabrera Y; Rocha-Moreno YG; Gascón-Lastiri G; Rivera-Márquez H; Wanzke-del-Angel V; Cerecedo-Díaz F; de la Cruz-Yañez H
    Arch Med Res; 2008 Oct; 39(7):655-62. PubMed ID: 18760193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinico-pathological features of pilomyxoid astrocytoma of the optic pathway.
    Chikai K; Ohnishi A; Kato T; Ikeda J; Sawamura Y; Iwasaki Y; Itoh T; Sawa H; Nagashima K
    Acta Neuropathol; 2004 Aug; 108(2):109-14. PubMed ID: 15168135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-grade glioma in children under 5 years of age: a chemotherapy only approach with the BBSFOP protocol.
    Dufour C; Grill J; Lellouch-Tubiana A; Puget S; Chastagner P; Frappaz D; Doz F; Pichon F; Plantaz D; Gentet JC; Raquin MA; Kalifa C
    Eur J Cancer; 2006 Nov; 42(17):2939-45. PubMed ID: 16962317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined intraarterial carboplatin, intraarterial etoposide phosphate, and IV Cytoxan chemotherapy for progressive optic-hypothalamic gliomas in young children.
    Osztie E; Várallyay P; Doolittle ND; Lacy C; Jones G; Nickolson HS; Neuwelt EA
    AJNR Am J Neuroradiol; 2001 May; 22(5):818-23. PubMed ID: 11337321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor stabilization under treatment with imatinib in progressive hypothalamic-chiasmatic glioma.
    Peyrl A; Azizi A; Czech T; Gruber-Olipitz M; Jones N; Haberler C; Prayer D; Autzinger E; Slavc I
    Pediatr Blood Cancer; 2009 Apr; 52(4):476-80. PubMed ID: 19061223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful combination chemotherapy (vincristine, procarbazine, etoposide, and prednisolone) in the treatment of inoperable, radioresistant low grade astrocytoma: a case report.
    Maipang MVasiknanonte P; Janjindamai SHirunpat S
    J Med Assoc Thai; 2000 Dec; 83(12):1525-9. PubMed ID: 11253894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemotherapy of brain tumors in children].
    Chastagner P; Olive-Sommelet D
    Arch Fr Pediatr; 1990 Feb; 47(2):147-54. PubMed ID: 2183741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of metronomic maintenance chemotherapy following high-dose chemotherapy for malignant central nervous system tumors.
    Choi LM; Rood B; Kamani N; La Fond D; Packer RJ; Santi MR; Macdonald TJ
    Pediatr Blood Cancer; 2008 May; 50(5):970-5. PubMed ID: 17941070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.